Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJun 29, 2026
DataAggregated Company Financials
Companies7
- 7D4.5%
- 3M13.7%
- 1Y-8.1%
- YTDn/a
In the last week, the Clinical Research and Equipment industry is up 4.5%, with Oxford Nanopore Technologies up 9.6%. In the same time, hVIVO was down 12%. In the past year, the industry is down 8.1%. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 29 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1265.7x | -8.5x | 4.4x |
| Wed, 27 May 2026 | UK£1.5b | UK£323.0m | -UK£166,018,254.00 | 1317.9x | -9.2x | 4.7x |
| Fri, 24 Apr 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.1x | 4.2x |
| Sun, 22 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 8.9x | -8.5x | 4.2x |
| Tue, 17 Feb 2026 | UK£1.5b | UK£304.6m | -UK£159,441,254.00 | 11.3x | -9.4x | 4.9x |
| Thu, 15 Jan 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 8.1x | -10.6x | 5.5x |
| Sat, 13 Dec 2025 | UK£1.4b | UK£304.4m | -UK£160,881,254.00 | 6.8x | -8.8x | 4.6x |
| Mon, 10 Nov 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.2x | -9.6x | 5.2x |
| Wed, 08 Oct 2025 | UK£1.7b | UK£304.3m | -UK£163,156,254.00 | 8.5x | -10.4x | 5.6x |
| Fri, 05 Sep 2025 | UK£1.8b | UK£313.4m | -UK£158,068,352.00 | 6.4x | -11.4x | 5.8x |
| Sun, 03 Aug 2025 | UK£2.1b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.3x | 7.3x |
| Tue, 01 Jul 2025 | UK£1.5b | UK£291.9m | -UK£160,968,352.00 | 7x | -9.5x | 5.2x |
| Thu, 29 May 2025 | UK£1.6b | UK£319.6m | -UK£190,979,785.00 | 10.2x | -8.5x | 5.1x |
| Sat, 26 Apr 2025 | UK£1.6b | UK£313.9m | -UK£192,362,214.35 | 10.9x | -8.4x | 5.1x |
| Mon, 24 Mar 2025 | UK£1.6b | UK£315.6m | -UK£186,234,564.20 | 6x | -8.5x | 5x |
| Wed, 19 Feb 2025 | UK£1.8b | UK£306.5m | -UK£195,180,498.48 | 7x | -9.4x | 6x |
| Fri, 17 Jan 2025 | UK£2.1b | UK£307.6m | -UK£196,033,516.80 | 7.1x | -10.7x | 6.8x |
| Sun, 15 Dec 2024 | UK£2.1b | UK£306.4m | -UK£195,163,702.56 | 8.5x | -10.8x | 6.9x |
| Tue, 12 Nov 2024 | UK£1.9b | UK£305.1m | -UK£193,004,299.12 | 11.1x | -10x | 6.3x |
| Thu, 10 Oct 2024 | UK£2.0b | UK£304.4m | -UK£192,350,536.90 | 10.3x | -10.6x | 6.7x |
| Sat, 07 Sep 2024 | UK£2.0b | UK£293.4m | -UK£192,317,721.90 | 12.2x | -10.4x | 6.8x |
| Mon, 05 Aug 2024 | UK£1.8b | UK£295.5m | -UK£189,945,748.23 | 12.6x | -9.7x | 6.2x |
| Wed, 03 Jul 2024 | UK£1.5b | UK£295.9m | -UK£190,219,269.39 | 11.5x | -7.9x | 5.1x |
| Fri, 31 May 2024 | UK£1.6b | UK£295.6m | -UK£189,825,740.04 | 11.3x | -8.5x | 5.5x |
| Sun, 28 Apr 2024 | UK£1.5b | UK£292.9m | -UK£189,020,345.45 | 7254.7x | -7.7x | 5x |
| Tue, 26 Mar 2024 | UK£1.8b | UK£295.9m | -UK£213,186,589.21 | 7352.9x | -8.3x | 6x |
| Thu, 22 Feb 2024 | UK£1.9b | UK£285.9m | -UK£189,294,445.63 | 6961.7x | -9.9x | 6.6x |
| Sat, 20 Jan 2024 | UK£2.9b | UK£450.2m | -UK£176,590,140.00 | 62.1x | -16.2x | 6.4x |
| Mon, 18 Dec 2023 | UK£3.1b | UK£450.1m | -UK£174,093,562.00 | 54.8x | -17.6x | 6.8x |
| Wed, 15 Nov 2023 | UK£3.0b | UK£455.7m | -UK£168,812,508.00 | 48.6x | -17.9x | 6.6x |
| Fri, 13 Oct 2023 | UK£3.0b | UK£458.6m | -UK£165,609,758.00 | 52.7x | -18x | 6.5x |
| Sun, 10 Sep 2023 | UK£3.1b | UK£440.5m | -UK£166,985,165.00 | 69.6x | -18.6x | 7x |
| Tue, 08 Aug 2023 | UK£3.4b | UK£476.5m | -UK£124,657,875.00 | 70.6x | -27x | 7.1x |
| Thu, 06 Jul 2023 | UK£2.9b | UK£476.6m | -UK£124,781,543.00 | 66.1x | -23.6x | 6.2x |
Price to Earnings Ratio
-23.6x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.14% | |
| Healthcare | 6.15% | |
| Life Sciences | 4.55% | |
| Clinical Research and Equipment | 4.55% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.24 | 9.6% +UK£106.0m | -9.3% | PS5.4x | |
| PRM Proteome Sciences | UK£0.017 | 14.3% +UK£754.1k | -43.8% | PS1.6x | |
| GDR genedrive | UK£0.013 | 2.0% +UK£401.4k | -7.1% | PS17.8x |